Cipla Valid
CEP Certificates (EDQM COS List)
Cipla Valid
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 68
- Latest End Date -
- Data Source EDQM
- Last Updated 2026-04-22
Company Overview
Social Profiles
Company Snapshot
Cipla Valid
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra 400 013
India
www.cipla.com/ corporate.one@cipla.com View on MapCEP Records Timeline (68 records)
Product
Granisetron hydrochloride
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-051 - Rev 03
Substance No.
1695
Issue Date
2026-04-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-051 - Rev 03
Substance No.: 1695
Product
Salbutamol sulfate, Process III, Non-micronised and Micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2025-002 - Rev 01
Substance No.
687
Issue Date
2026-04-16
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-002 - Rev 01
Substance No.: 687
Product
Sorafenib tosilate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2024-167 - Rev 00
Substance No.
2931
Issue Date
2026-02-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-167 - Rev 00
Substance No.: 2931
Product
Amlodipine besilate, Process II
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2015-140 - Rev 02
Substance No.
1491
Issue Date
2026-02-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2015-140 - Rev 02
Substance No.: 1491
Product
Salmeterol xinafoate, Micronised, grades I and II
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2006-296 - Rev 06
Substance No.
1765
Issue Date
2026-01-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2006-296 - Rev 06
Substance No.: 1765
Product
Pirfenidone
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2018-096 - Rev 01
Substance No.
2856
Issue Date
2025-10-31
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-096 - Rev 01
Substance No.: 2856
Product
Omeprazole sodium
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-276 - Rev 04
Substance No.
1032
Issue Date
2025-10-30
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-276 - Rev 04
Substance No.: 1032
Product
Cetirizine dihydrochloride
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2000-081 - Rev 08
Substance No.
1084
Issue Date
2025-10-14
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2000-081 - Rev 08
Substance No.: 1084
Product
Lamivudine, Form II
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-103 - Rev 04
Substance No.
2217
Issue Date
2025-09-26
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-103 - Rev 04
Substance No.: 2217
Product
Esomeprazole magnesium dihydrate, Micronised 1 and Micronised 2
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2014-077 - Rev 02
Substance No.
2787
Issue Date
2025-09-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-077 - Rev 02
Substance No.: 2787
Product
Rivastigmine hydrogen tartrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2014-053 - Rev 01
Substance No.
2630
Issue Date
2025-08-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-053 - Rev 01
Substance No.: 2630
Product
Beclometasone dipropionate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2005-015 - Rev 05
Substance No.
654
Issue Date
2025-08-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2005-015 - Rev 05
Substance No.: 654
Product
Citalopram hydrobromide
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2009-012 - Rev 02
Substance No.
2288
Issue Date
2025-07-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2009-012 - Rev 02
Substance No.: 2288
Product
Mometasone furoate monohydrate, Micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2018-290 - Rev 02
Substance No.
2858
Issue Date
2025-06-18
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-290 - Rev 02
Substance No.: 2858
Product
Omeprazole
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 1997-122 - Rev 06
Substance No.
942
Issue Date
2025-06-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 1997-122 - Rev 06
Substance No.: 942
Product
Terbinafine hydrochloride
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-028 - Rev 05
Substance No.
1734
Issue Date
2025-06-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-028 - Rev 05
Substance No.: 1734
Product
Gefitinib, Micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2017-002 - Rev 01
Substance No.
2866
Issue Date
2025-05-21
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-002 - Rev 01
Substance No.: 2866
Product
Cyproterone acetate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-038 - Rev 04
Substance No.
1094
Issue Date
2025-04-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-038 - Rev 04
Substance No.: 1094
Product
Ondansetron hydrochloride dihydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2006-279 - Rev 04
Substance No.
2016
Issue Date
2025-02-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2006-279 - Rev 04
Substance No.: 2016
Product
Trimetazidine dihydrochloride
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-231 - Rev 04
Substance No.
1741
Issue Date
2025-01-03
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-231 - Rev 04
Substance No.: 1741
Product
Fluticasone propionate, Modified Process II, Micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2020-075 - Rev 02
Substance No.
1750
Issue Date
2024-10-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2020-075 - Rev 02
Substance No.: 1750
Product
Fluticasone propionate, Process III, micronised grade I, II, III
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2012-056 - Rev 05
Substance No.
1750
Issue Date
2024-10-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2012-056 - Rev 05
Substance No.: 1750
Product
Etoposide
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2007-061 - Rev 06
Substance No.
823
Issue Date
2024-09-17
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-061 - Rev 06
Substance No.: 823
Product
Pramipexole dihydrochloride monohydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2011-047 - Rev 03
Substance No.
2416
Issue Date
2024-07-05
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2011-047 - Rev 03
Substance No.: 2416
Product
Budesonide
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2006-061 - Rev 03
Substance No.
1075
Issue Date
2024-06-21
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2006-061 - Rev 03
Substance No.: 1075
Product
Fluticasone propionate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2006-078 - Rev 03
Substance No.
1750
Issue Date
2024-06-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2006-078 - Rev 03
Substance No.: 1750
Product
Risperidone
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2005-037 - Rev 03
Substance No.
1559
Issue Date
2024-05-23
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2005-037 - Rev 03
Substance No.: 1559
Product
Escitalopram oxalate, Process-II
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2023-413 - Rev 00
Substance No.
2733
Issue Date
2024-05-16
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2023-413 - Rev 00
Substance No.: 2733
Product
Lamotrigine
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2010-212 - Rev 02
Substance No.
1756
Issue Date
2024-03-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2010-212 - Rev 02
Substance No.: 1756
Product
Escitalopram oxalate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2017-099 - Rev 01
Substance No.
2733
Issue Date
2024-03-11
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2017-099 - Rev 01
Substance No.: 2733
Product
Salbutamol sulfate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2005-080 - Rev 06
Substance No.
687
Issue Date
2024-03-07
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2005-080 - Rev 06
Substance No.: 687
Product
Salbutamol sulfate, Code 6885
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
CEP 2011-314 - Rev 03
Substance No.
687
Issue Date
2024-03-07
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2011-314 - Rev 03
Substance No.: 687
Product
Budesonide, Process II, micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R0-CEP 2023-094 - Rev 00
Substance No.
1075
Issue Date
2023-08-24
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2023-094 - Rev 00
Substance No.: 1075
Product
Solifenacin succinate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2017-062 - Rev 00
Substance No.
2779
Issue Date
2023-08-16
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2017-062 - Rev 00
Substance No.: 2779
Product
Celecoxib
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2014-186 - Rev 01
Substance No.
2591
Issue Date
2023-05-30
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2014-186 - Rev 01
Substance No.: 2591
Product
Felodipine
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 1999-022 - Rev 05
Substance No.
1013
Issue Date
2023-04-06
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 1999-022 - Rev 05
Substance No.: 1013
Product
Rivaroxaban
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R0-CEP 2021-278 - Rev 00
Substance No.
2932
Issue Date
2023-03-06
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2021-278 - Rev 00
Substance No.: 2932
Product
Entecavir monohydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2016-051 - Rev 00
Substance No.
2815
Issue Date
2023-01-23
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-051 - Rev 00
Substance No.: 2815
Product
Meloxicam, Micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2009-040 - Rev 05
Substance No.
2373
Issue Date
2022-11-04
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2009-040 - Rev 05
Substance No.: 2373
Product
Esomeprazole magnesium trihydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2015-320 - Rev 00
Substance No.
2372
Issue Date
2022-08-22
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-320 - Rev 00
Substance No.: 2372
Product
Exemestane
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2016-072 - Rev 00
Substance No.
2766
Issue Date
2022-08-19
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-072 - Rev 00
Substance No.: 2766
Product
Tiotropium bromide monohydrate, micronised
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2016-089 - Rev 00
Substance No.
2420
Issue Date
2022-06-29
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-089 - Rev 00
Substance No.: 2420
Product
Finasteride
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2005-025 - Rev 05
Substance No.
1615
Issue Date
2022-04-12
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2005-025 - Rev 05
Substance No.: 1615
Product
Fluticasone propionate, Process II, micronised, grades I and II
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2012-001 - Rev 02
Substance No.
1750
Issue Date
2022-03-14
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2012-001 - Rev 02
Substance No.: 1750
Product
Ciclesonide
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2015-223 - Rev 00
Substance No.
2703
Issue Date
2022-01-06
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-223 - Rev 00
Substance No.: 2703
Product
Formoterol fumarate dihydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2005-184 - Rev 03
Substance No.
1724
Issue Date
2022-01-05
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2005-184 - Rev 03
Substance No.: 1724
Product
Bicalutamide
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2014-191 - Rev 00
Substance No.
2196
Issue Date
2021-08-03
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2014-191 - Rev 00
Substance No.: 2196
Product
Imatinib mesilate, Alpha form
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2015-230 - Rev 00
Substance No.
2736
Issue Date
2021-05-05
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-230 - Rev 00
Substance No.: 2736
Product
Cisplatin
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2014-155 - Rev 00
Substance No.
599
Issue Date
2021-03-03
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2014-155 - Rev 00
Substance No.: 599
Product
Desloratadine
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2014-359 - Rev 00
Substance No.
2570
Issue Date
2021-02-08
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2014-359 - Rev 00
Substance No.: 2570
Product
Risedronate sodium 2.5-hydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2014-130 - Rev 00
Substance No.
2572
Issue Date
2020-04-28
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2014-130 - Rev 00
Substance No.: 2572
Product
Lansoprazole
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2011-340 - Rev 00
Substance No.
2219
Issue Date
2020-01-23
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2011-340 - Rev 00
Substance No.: 2219
Product
Ramipril
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-024 - Rev 03
Substance No.
1368
Issue Date
2019-10-09
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-024 - Rev 03
Substance No.: 1368
Product
Carboplatin
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2005-125 - Rev 03
Substance No.
1081
Issue Date
2019-09-16
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2005-125 - Rev 03
Substance No.: 1081
Product
Mometasone furoate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-112 - Rev 03
Substance No.
1449
Issue Date
2019-08-16
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-112 - Rev 03
Substance No.: 1449
Product
Oxaliplatin
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-296 - Rev 02
Substance No.
2017
Issue Date
2019-07-26
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-296 - Rev 02
Substance No.: 2017
Product
Letrozole
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2010-300 - Rev 00
Substance No.
2334
Issue Date
2019-07-08
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2010-300 - Rev 00
Substance No.: 2334
Product
Tamsulosin hydrochloride, A Code
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-131 - Rev 02
Substance No.
2131
Issue Date
2018-10-15
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-131 - Rev 02
Substance No.: 2131
Product
Sodium alendronate trihydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2005-126 - Rev 04
Substance No.
1564
Issue Date
2018-08-29
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2005-126 - Rev 04
Substance No.: 1564
Product
Omeprazole magnesium
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2010-310 - Rev 00
Substance No.
2374
Issue Date
2018-06-13
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2010-310 - Rev 00
Substance No.: 2374
Product
Carvedilol
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2005-124 - Rev 03
Substance No.
1745
Issue Date
2018-03-09
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2005-124 - Rev 03
Substance No.: 1745
Product
Fluconazole
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-141 - Rev 01
Substance No.
2287
Issue Date
2018-01-04
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-141 - Rev 01
Substance No.: 2287
Product
Praziquantel
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-081 - Rev 03
Substance No.
855
Issue Date
2017-05-22
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-081 - Rev 03
Substance No.: 855
Product
Pantoprazole sodium sesquihydrate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2008-218 - Rev 01
Substance No.
2296
Issue Date
2017-01-06
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2008-218 - Rev 01
Substance No.: 2296
Product
Venlafaxine hydrochloride, Form C
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-039 - Rev 03
Substance No.
2119
Issue Date
2015-07-08
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-039 - Rev 03
Substance No.: 2119
Product
Amlodipine besilate
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2006-067 - Rev 01
Substance No.
1491
Issue Date
2014-07-28
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2006-067 - Rev 01
Substance No.: 1491
Product
Leflunomide
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-050 - Rev 01
Substance No.
2330
Issue Date
2014-07-28
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-050 - Rev 01
Substance No.: 2330
Product
Venlafaxine hydrochloride, Form B
Substance
CIPLA LIMITED Mumbai IN
Certificate No.
R1-CEP 2007-040 - Rev 00
Substance No.
2119
Issue Date
2014-07-23
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-040 - Rev 00
Substance No.: 2119
Status Breakdown
68 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: CEP 2007-051 - Rev 03
Substance No.: 1695
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.